CTI Biopharma reported $1.2B in Market Capitalization this June of 2023, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Baxter International USD 9.82B 1.87B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Geron USD 843M 31M Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Northwest Biotherapeutics USD 246M 110M Apr/2026
Novartis USD 292.21B 26.55B Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
Plus Therapeutics USD 17M 54M Apr/2026